Clinical correlates of enlarged prostate size in subjects with sexual dysfunction

Digito-rectal examination (DRE) of the prostate provides useful information on the state of prostate growth and on the presence of suspected peripheral nodules. The aim of this study is to describe the clinical and biochemical correlates of finding an enlarged prostate size at DRE in subjects with s...

Full description

Bibliographic Details
Main Authors: Giovanni Corona, Mauro Gacci, Elisa Maseroli, Giulia Rastrelli, Linda Vignozzi, Alessandra Sforza, Gianni Forti, Edoardo Mannucci, Mario Maggi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-10-01
Series:Asian Journal of Andrology
Subjects:
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=5;spage=767;epage=773;aulast=Corona
_version_ 1828446616557715456
author Giovanni Corona
Mauro Gacci
Elisa Maseroli
Giulia Rastrelli
Linda Vignozzi
Alessandra Sforza
Gianni Forti
Edoardo Mannucci
Mario Maggi
author_facet Giovanni Corona
Mauro Gacci
Elisa Maseroli
Giulia Rastrelli
Linda Vignozzi
Alessandra Sforza
Gianni Forti
Edoardo Mannucci
Mario Maggi
author_sort Giovanni Corona
collection DOAJ
description Digito-rectal examination (DRE) of the prostate provides useful information on the state of prostate growth and on the presence of suspected peripheral nodules. The aim of this study is to describe the clinical and biochemical correlates of finding an enlarged prostate size at DRE in subjects with sexual dysfunction (SD). A consecutive series of 2379 patients was retrospectively studied. The analysis was focused on a subset of subjects (n = 1823; mean age 54.7 ± 11.4) selected for being free from overt prostatic diseases. Several parameters were investigated. After adjusting for confounders, the presence of an enlarged prostate size at DRE was associated with a higher risk of metabolic syndrome (HR = 1.346 (1.129-1.759); P = 0.030), type 2 diabetes mellitus (HR = 1.489 (1.120-1.980); P = 0.006), increased LDL cholesterol (>100 mg dl−1 ; HR = 1.354 (1.018-1.801); P = 0.037) and increased mean blood pressure (BP) values (HR = 1.017 (1.007-1.027) for each mmHg increment; P = 0.001). Accordingly, enlarged prostate size was also associated with a higher risk of arteriogenic erectile dysfunction (ED), as well as with other andrological conditions, such as varicocele and premature ejaculation (PE). PSA levels were significantly higher in subjects with enlarged prostate size when compared to the rest of the sample (HR = 3.318 (2.304; 4.799) for each log unit increment in PSA levels; P < 0.0001). Arteriogenic ED, according to different criteria, was also associated with increased PSA levels. In conclusion, our data support the need to examine prostate size either by clinical (DRE) or biochemical (PSA) inspection in subjects with SD, in order to have insights into the nature of the SD and the metabolic and cardiovascular (CV) background of the patient.
first_indexed 2024-12-10T22:14:52Z
format Article
id doaj.art-bb6f894217604a6da3b7b169afcc0709
institution Directory Open Access Journal
issn 1008-682X
1745-7262
language English
last_indexed 2024-12-10T22:14:52Z
publishDate 2014-10-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Andrology
spelling doaj.art-bb6f894217604a6da3b7b169afcc07092022-12-22T01:31:30ZengWolters Kluwer Medknow PublicationsAsian Journal of Andrology1008-682X1745-72622014-10-0116576777310.4103/1008-682X.126382Clinical correlates of enlarged prostate size in subjects with sexual dysfunctionGiovanni CoronaMauro GacciElisa Maseroli Giulia RastrelliLinda Vignozzi Alessandra Sforza Gianni Forti Edoardo MannucciMario MaggiDigito-rectal examination (DRE) of the prostate provides useful information on the state of prostate growth and on the presence of suspected peripheral nodules. The aim of this study is to describe the clinical and biochemical correlates of finding an enlarged prostate size at DRE in subjects with sexual dysfunction (SD). A consecutive series of 2379 patients was retrospectively studied. The analysis was focused on a subset of subjects (n = 1823; mean age 54.7 ± 11.4) selected for being free from overt prostatic diseases. Several parameters were investigated. After adjusting for confounders, the presence of an enlarged prostate size at DRE was associated with a higher risk of metabolic syndrome (HR = 1.346 (1.129-1.759); P = 0.030), type 2 diabetes mellitus (HR = 1.489 (1.120-1.980); P = 0.006), increased LDL cholesterol (>100 mg dl−1 ; HR = 1.354 (1.018-1.801); P = 0.037) and increased mean blood pressure (BP) values (HR = 1.017 (1.007-1.027) for each mmHg increment; P = 0.001). Accordingly, enlarged prostate size was also associated with a higher risk of arteriogenic erectile dysfunction (ED), as well as with other andrological conditions, such as varicocele and premature ejaculation (PE). PSA levels were significantly higher in subjects with enlarged prostate size when compared to the rest of the sample (HR = 3.318 (2.304; 4.799) for each log unit increment in PSA levels; P < 0.0001). Arteriogenic ED, according to different criteria, was also associated with increased PSA levels. In conclusion, our data support the need to examine prostate size either by clinical (DRE) or biochemical (PSA) inspection in subjects with SD, in order to have insights into the nature of the SD and the metabolic and cardiovascular (CV) background of the patient.http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=5;spage=767;epage=773;aulast=Coronabenign prostatic hyperplasia; metabolic syndrome enlarged prostate size; testosterone
spellingShingle Giovanni Corona
Mauro Gacci
Elisa Maseroli
Giulia Rastrelli
Linda Vignozzi
Alessandra Sforza
Gianni Forti
Edoardo Mannucci
Mario Maggi
Clinical correlates of enlarged prostate size in subjects with sexual dysfunction
Asian Journal of Andrology
benign prostatic hyperplasia; metabolic syndrome enlarged prostate size; testosterone
title Clinical correlates of enlarged prostate size in subjects with sexual dysfunction
title_full Clinical correlates of enlarged prostate size in subjects with sexual dysfunction
title_fullStr Clinical correlates of enlarged prostate size in subjects with sexual dysfunction
title_full_unstemmed Clinical correlates of enlarged prostate size in subjects with sexual dysfunction
title_short Clinical correlates of enlarged prostate size in subjects with sexual dysfunction
title_sort clinical correlates of enlarged prostate size in subjects with sexual dysfunction
topic benign prostatic hyperplasia; metabolic syndrome enlarged prostate size; testosterone
url http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=5;spage=767;epage=773;aulast=Corona
work_keys_str_mv AT giovannicorona clinicalcorrelatesofenlargedprostatesizeinsubjectswithsexualdysfunction
AT maurogacci clinicalcorrelatesofenlargedprostatesizeinsubjectswithsexualdysfunction
AT elisamaseroli clinicalcorrelatesofenlargedprostatesizeinsubjectswithsexualdysfunction
AT giuliarastrelli clinicalcorrelatesofenlargedprostatesizeinsubjectswithsexualdysfunction
AT lindavignozzi clinicalcorrelatesofenlargedprostatesizeinsubjectswithsexualdysfunction
AT alessandrasforza clinicalcorrelatesofenlargedprostatesizeinsubjectswithsexualdysfunction
AT gianniforti clinicalcorrelatesofenlargedprostatesizeinsubjectswithsexualdysfunction
AT edoardomannucci clinicalcorrelatesofenlargedprostatesizeinsubjectswithsexualdysfunction
AT mariomaggi clinicalcorrelatesofenlargedprostatesizeinsubjectswithsexualdysfunction